Researcher - Dr Justin Sturge
Institution - University of Hull
Grant award - £100,000.00
Reference – S14-017
ENDOGLOW is a state of the art imaging tool that will allow us to accurately assess prostate cancer aggressiveness, giving patients and clinicians an early indication of whether treatment is necessary.
One of the biggest hurdles that faces clinicians treating prostate cancer patients is knowing when, or if, the cancer has become an aggressive one. At present large portions of the prostate are removed to ensure no potentially aggressive parts are left. This project will create a new system called ENDOGLOW that will be able to identify any cells in the prostate tissue that have adopted invasive behaviour. This work will help inform clinicians about the best treatment for the patient and help improve the quality of life and increase the survival rate of men with prostate cancer.